Nektar Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $21,807 | $11,790 | $11,175 | $10,460 |
Gross Profit | 21,807 | 11,594 | 11,175 | 10,460 |
EBITDA | -18,900 | -29,312 | -33,787 | -40,969 |
EBIT | -19,090 | -29,508 | -34,001 | -41,395 |
Net Income | -36,079 | -35,522 | -41,593 | -50,882 |
Net Change In Cash | 21,807 | 11,790 | 11,175 | 10,460 |
Free Cash Flow | -64,977 | -48,875 | -45,775 | -49,055 |
Cash | 15,116 | 41,032 | 42,988 | 38,894 |
Basic Shares | 20,296 | 14,087 | 14,087 | 14,061 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $55,232 | $98,427 | $90,122 | $92,055 |
Gross Profit | 55,232 | 67,741 | 53,478 | 70,420 |
EBITDA | -129,744 | -86,697 | -243,107 | -323,872 |
EBIT | -130,770 | -91,088 | -250,922 | -336,072 |
Net Income | -164,076 | -118,961 | -276,056 | -368,198 |
Net Change In Cash | 55,232 | 98,427 | 90,122 | 92,055 |
Free Cash Flow | -208,682 | -177,177 | -193,471 | -309,683 |
Cash | 15,116 | 44,252 | 35,277 | 88,227 |
Basic Shares | 16,870 | 13,710 | 12,666 | 12,475 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.28 |
2025-09-30 | -$1.87 |
2025-06-30 | -$2.95 |
2025-03-31 | -$0.24 |
